Serum CK-MB activity in progressive muscular dystrophy: is it of nosologic value?
Serum creatine-kinase (CK) isoenzyme MB was measured in 53 patients affected by different types of myopathies (20 with Duchenne muscular dystrophy (DMD), eight with the Becker form (BMD), ten with the limb-girdle form (LGMD), six with the facioscapulohumeral form (FSH), and nine affected by polymyositis and in 21 normal control subjects). The aim of this study was to compare each group with the control individuals and to assess the nosologic value of CK-MB activity among some clinically similar dystrophies, which may have an important application for genetic counseling. A statistically significant increased CK-MB activity was found only in the Duchenne and Becker patients when compared with control persons (p less than 0.05). When the different groups of patients were compared among themselves, no significant difference was found between DMD and BMD or LGMD and polymyositis. However, a significant difference was found between BMD and LGMD. Based on these data, it is possible, through discriminant analysis, to estimate the relative biochemical probability of an isolated male patient belonging to either group.
D000328:Adult; D002648:Child; D003402:Creatine Kinase / Q000097:blood*; D003937:Diagnosis, Differential; D008040:Genetic Linkage; D006801:Humans; D007527:Isoenzymes; D008297:Male; D009136:Muscular Dystrophies / Q000175:diagnosis / Q000201:enzymology* / Q000235:genetics; D014960:X Chromosome
D007527:Isoenzymes; D003402:Creatine Kinase